Plasma and whole blood clot strength measured by thrombelastography in patients treated with clopidogrel during acute coronary syndromes

Thrombosis Research

Volumn 132, Issue 2, 2013, Pages

  Lu, Deshun ^a   Owens, Janelle ^a   Kreutz, Rolf P ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Clopidogrel; Coagulation; CRP; Platelet; Thrombelastography

Indexed keywords

C REACTIVE PROTEIN; CLOPIDOGREL; FIBRINOGEN;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TEST; BLOOD SAMPLING; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PLASMA; PLATELET REACTIVITY; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY;

ACS; ACUTE CORONARY SYNDROME; ADENOSINE 5'-DIPHOSPHATE; ADP; ANGLE CONSTANT; C-REACTIVE PROTEIN; CLOPIDOGREL; CLOT FORMATION TIME; COAGULATION; CRP; DIFF; DIFFERENCE; G; K; LIGHT TRANSMITTANCE AGGREGOMETRY; LTA; MA; MAXIMUM AMPLITUDE; MAXIMUM CLOT STRENGTH; NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NSTEMI; PLATELET; PLATELET POOR PLASMA; PLATELET RICH PLASMA; PPP; PRP; R; THROMBELASTOGRAPHY; THROMBIN RECEPTOR ACTIVATION PEPTIDE; TIME TO FIBRIN FORMATION; TRAP; Α;

ACUTE CORONARY SYNDROME; C-REACTIVE PROTEIN; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; THROMBELASTOGRAPHY; TICLOPIDINE;

EID: 84883810776     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.07.012     Document Type: Article

References (33)

1. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, and K.K. Fox Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation N Engl J Med 345 7 2001 494 502
2. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, and K.K. Fox Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation N Engl J Med 345 20 2001 1506
3. P. Savi, J.-L. Zachayus, N. Delesque-Touchard, C. Labouret, C. Hervé, and M.-F. Uzabiaga The active metabolite of clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts Proc Natl Acad Sci U S A 103 29 2006 11069 11074
4. J.-M. Pereillo, M. Maftouh, A. Andrieu, M.-F. Uzabiaga, O. Fedeli, and P. Savi Structure and Stereochemistry of the Active Metabolite of C(1)lopidogrel Drug Metab Dispos 30 11 2002 1288 1295
5. N.J. Breet, J.W. van Werkum, H.J. Bouman, J.C. Kelder, H.J. Ruven, E.T. Bal, V.H. Deneer, A.M. Harmsze, J.A. van der Heyden, B.J. Rensing, M.J. Suttorp, C.M. Hackeng, and J.M. ten Berg Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent Implantation JAMA 303 2010 754 762
6. M. Kannan, and R. Saxena Glanzmann's Thrombasthenia: An Overview Clin Appl Thromb Hemost 15 2 2009 152 165
7. A.I. Schafer Thrombocytosis N Engl J Med 350 12 2004 1211 1219
8. R.M. Camire, E.S. Pollak, K. Kaushansky, and P.B. Tracy Secretable Human Platelet-Derived Factor V Originates From the Plasma Pool Blood 92 9 1998 3035 3041
9. R. Kreutz, J. Owens, J. Breall, D. Lu, E. von der Lohe, and I. Bolad C-reactive protein and fibrin clot strength measured by thrombelastoghraphy after coronary stenting Blood Coagul Fibrinolysis 24 3 2013 321 326
10. K. Thygesen, J.S. Alpert, and H.D. White Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction Circulation 116 22 2007 2634 2653
11. R.P. Kreutz, J.A. Breall, Y. Kreutz, J. Owens, D. Lu, and I. Bolad Protease activated receptor-1 (PAR-1) mediated platelet aggregation is dependent on clopidogrel response Thromb Res 130 2 2012 198 202
12. P. Libby Inflammation in Atherosclerosis Arterioscler Thromb 32 9 2012 2045 2051
13. S. Kaptoge, E. Di Angelantonio, L. Pennells, A.M. Wood, I.R. White, and P. Gao C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction N Engl J Med 367 14 2012 1310 1320
14. R. Li, M. Ren, M. Luo, N. Chen, Z. Zhang, and B. Luo Monomeric C-reactive protein alters fibrin clot properties on endothelial cells Thromb Res 129 5 2012 e251 e256
15. V.A. Bowbrick, D.P. Mikhailidis, and G. Stansby Value of Thromboelastography in the Assessment of Platelet Function Clin Appl Thromb Hemost 9 2 2003 137 142
16. L.A. Bailey, J.J. Sistino, and W.E. Uber Is platelet function as measured by Thrombelastograph monitoring in whole blood affected by platelet inhibitors? J Extra Corpor Technol 37 1 2005 43 47
17. P.A. Gurbel, K.P. Bliden, K. Guyer, P.W. Cho, K.A. Zaman, R.P. Kreutz, A.K. Bassi, and U.S. Tantry Platelet Reactivity in Patients and Recurrent Events Post-Stenting: Results of the PREPARE POST-STENTING Study J Am Coll Cardiol 46 10 2005 1820 1826
18. P.A. Gurbel, K.P. Bliden, I.A. Navickas, E. Mahla, J. Dichiara, T.A. Suarez, M.J. Antonino, U.S. Tantry, and E. Cohen Adenosine diphosphate-induced platelet-fibrin clot strength: a new thrombelastographic indicator of long-term poststenting ischemic events Am Heart J 160 2 2010 346 354
19. S. Rafiq, P.I. Johansson, S.R. Ostrowski, T. Stissing, and D.A. Steinbrüchel Hypercoagulability in patients undergoing coronary artery bypass grafting: prevalence, patient characteristics and postoperative outcome Eur J Cardiothorac Surg 41 3 2012 550 555
20. D.J. McCrath, E. Cerboni, R.J. Frumento, A.L. Hirsh, and E. Bennett-Guerrero Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction Anesth Analg 100 6 2005 1576 1583
21. U.S. Tantry, K.P. Bliden, T.A. Suarez, R.P. Kreutz, J. Dichiara, and P.A. Gurbel Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: results of the Thrombotic RIsk Progression (TRIP) study Platelets 21 5 2010 360 367
22. V.G. Nielsen, W.Q. Gurley Jr., and T.M. Burch The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography Anesth Analg 99 1 2004 120 123
23. V. Schroeder, T. Chatterjee, and H.P. Kohler Influence of blood coagulation factor XIII and FXIII Val34Leu on plasma clot formation measured by thrombelastography Thromb Res 104 6 2001 467 474
24. J. McDonagh, R.P. McDonagh, C.E. Del, J.M. Ge, and R.H. Wagner Factor XIII in human plasma and platelets J Clin Invest 48 5 1969 940 946
25. D.V. Devine, G. Andestad, D. Nugent, and C.J. Carter Platelet-associated factor XIII as a marker of platelet activation in patients with peripheral vascular disease Arterioscler Thromb 13 6 1993 857 862
26. V.G. Nielsen, J.B. Cohen, S.N. Malayaman, M. Nowak, and K. Vosseller Fibrinogen is a heme-associated, carbon monoxide sensing molecule: a preliminary report Blood Coagul Fibrinolysis 22 5 2011 443 447
27. V.G. Nielsen, M.R. Arkebauer, K.A. Wasko, S.N. Malayaman, and K. Vosseller Carbon monoxide-releasing molecule-2 decreases fibrinolysis in vitro and in vivo in the rabbit Blood Coagul Fibrinolysis 23 1 2012 104 107
28. V.G. Nielsen, M.R. Arkebauer, and K. Vosseller Redox-based thrombelastographic method to detect carboxyhemefibrinogen-mediated hypercoagulability Blood Coagul Fibrinolysis 22 8 2011 657 661
29. K.A. Machovec, D.S. Ushakumari, I.J. Welsby, and V.G. Nielsen The procoagulant properties of purified fibrinogen concentrate are enhanced by carbon monoxide releasing molecule-2 Thromb Res 129 6 2012 793 796
30. M.C. Smith, and V.G. Nielsen Detection of carboxyhemefibrinogen and methemefibrinogen in a patient with thrombosis of a HeartMate II ventricular assist device ASAIO J 59 1 2013 93 95
31. V.G. Nielsen, D.T. Hafner, and E.B. Steinbrenner Tobacco smoke-induced hypercoagulation in human plasma: role of carbon monoxide Blood Coagul Fibrinolysis 24 4 2013 405 410
32. B. Hedblad, G. Engström, E. Janzon, G. Berglund, and L. Janzon COHb% as a marker of cardiovascular risk in never smokers: results from a population-based cohort study Scand J Public Health 34 6 2006 609 615
33. S. Elsasser, T. Mall, M. Grossenbacher, M. Zuber, A.P. Perruchoud, and R. Ritz Influence of carbon monoxide (CO) on the early course of acute myocardial infarction Intensive Care Med 21 9 1995 716 722